124. 皮質下梗塞と白質脳症を伴う常染色体優性脳動脈症
[臨床試験数:11,薬物数:13(DrugBank:4),標的遺伝子数:3,標的パスウェイ数:11

Searched query = "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", "CADASIL", "Autosomal dominant cerebral artery disease with subcortical infarct and leukoencephalopathy", "Autosomal dominant cerebral artery disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01361763
(ClinicalTrials.gov)
June 201116/5/2011Safety Study of Dabigatran in CADASILPhase II, Randomized, Crossover, Single Blind, Safety Trial of DABIGATRAN Versus ASA for Preventing Ischaemic Brain Lesions in Patients Affected by CADASILCADASILDrug: Dabigatran;Drug: AntiplateletsS. Andrea HospitalNULLRecruiting18 YearsN/ABoth50Phase 2Italy